Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof

Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof

US Patent 9475814 · Granted Oct 25, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deu2024
Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deu2024
Piperidine derivatives as METTL3 inhibitors2024
Piperidine derivatives as METTL3 inhibitors2024
Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbony2024
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
NK-3 receptor antagonists for therapeutic treatment of leptin-related disease2022
NK-3 receptor antagonists for therapeutic treatment of leptin-related disease2022